首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   480篇
  免费   13篇
  国内免费   13篇
儿科学   15篇
妇产科学   7篇
基础医学   35篇
口腔科学   5篇
临床医学   44篇
内科学   121篇
皮肤病学   20篇
神经病学   9篇
特种医学   160篇
外科学   42篇
综合类   3篇
预防医学   13篇
药学   14篇
中国医学   1篇
肿瘤学   17篇
  2024年   1篇
  2023年   1篇
  2022年   2篇
  2021年   6篇
  2020年   4篇
  2019年   5篇
  2018年   4篇
  2017年   6篇
  2016年   9篇
  2015年   5篇
  2014年   10篇
  2013年   18篇
  2012年   19篇
  2011年   16篇
  2010年   16篇
  2009年   17篇
  2008年   18篇
  2007年   29篇
  2006年   12篇
  2005年   9篇
  2004年   6篇
  2003年   5篇
  2002年   6篇
  2001年   1篇
  2000年   4篇
  1999年   5篇
  1998年   14篇
  1997年   22篇
  1996年   24篇
  1995年   15篇
  1994年   17篇
  1993年   12篇
  1992年   3篇
  1991年   3篇
  1990年   11篇
  1989年   26篇
  1988年   15篇
  1987年   22篇
  1986年   18篇
  1985年   21篇
  1984年   15篇
  1983年   7篇
  1982年   5篇
  1981年   3篇
  1980年   3篇
  1979年   3篇
  1978年   1篇
  1977年   3篇
  1976年   3篇
  1975年   6篇
排序方式: 共有506条查询结果,搜索用时 15 毫秒
501.
502.
The combination of cell therapy with growth factors could be a useful approach to treat progressive muscular dystrophies. Here, we demonstrate, for the first time, that IGF-1 considerably enhances the myogenesis of human umbilical cord (UC) mesenchymal stromal cells (MSCs) in vitro and that IGF-1 enhances interaction and restoration of dystrophin expression in co-cultures of MSCs and muscle cells from Duchenne patients. In vivo studies showed that human MSCs were able to reach the skeletal muscle of LAMA2 dy/2j dystrophic mice, through systemic delivery, without immunosuppression. Moreover, we showed, for the first time, that IGF-1 injected systemically together with MSCs markedly reduced muscle inflammation and fibrosis, and significantly improved muscle strength in dystrophic mice. Our results suggest that a combined treatment with IGF-1 and MSCs enhances efficiency of muscle repair and, therefore, should be further considered as a potential therapeutic approach in muscular dystrophies.  相似文献   
503.
504.
OBJECTIVE: Epilepsy is the most common neurological disorder in the world, yet it is still widely misunderstood. A lack of knowledge and negative attitudes about epilepsy are largely blamed for the stigma felt by people with epilepsy and their families. Recent calls for research into stigma have been made by the World Health Organization and international epilepsy organizations. Our objective is to describe the development, structure, and psychometric properties of the Thinking about Epilepsy questionnaire. METHODS: A 36-item questionnaire was designed to assess Grade 5 (ages 9-11) students' knowledge of and attitudes about epilepsy and to evaluate changes in knowledge and attitudes following an epilepsy education program. The questionnaire contains 18 knowledge, 10 attitude, and 8 demographic questions. RESULTS: Psychometric properties of the Thinking about Epilepsy questionnaire were ascertained using data from 783 Grade 5 students. Three items (one knowledge item and two attitude items) were removed prior to the factor analysis due to their low extraction communalities. Factor analysis revealed a bidimensional structure (knowledge and attitudes) with five knowledge factors and two attitude factors. The questionnaire was found to have good internal consistency reliability (Cronbach's alpha=0.74 for knowledge and 0.82 for attitudes). Both the knowledge and attitude measures were deemed to have acceptable face, content, and construct validity. CONCLUSION: The final 33-item Thinking about Epilepsy questionnaire demonstrates adequate reliability for the knowledge measure, good reliability for the attitude measure, and excellent validity for both measures. The Thinking about Epilepsy questionnaire offers a viable option for assessing elementary school students' knowledge and attitudes regarding epilepsy in general or in conjunction with its affiliated Thinking about Epilepsy education program.  相似文献   
505.
506.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号